Moderna Slips As Issues At Partners Delay Overseas Release Of Shots
- ByInvesting.com-
- 1
By Dhirendra Tripathi Investing.com – Moderna (NASDAQ:MRNA) stock fell more than 4% as the company said issues at its manufacturing partners’ end have slowed down the release of...